0001375151-19-000036.txt : 20190319
0001375151-19-000036.hdr.sgml : 20190319
20190319190123
ACCESSION NUMBER: 0001375151-19-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190315
FILED AS OF DATE: 20190319
DATE AS OF CHANGE: 20190319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Michael P
CENTRAL INDEX KEY: 0001355576
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19693159
MAIL ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_155303646820835.xml
FORM 4
X0306
4
2019-03-15
0
0001375151
ZOGENIX, INC.
ZGNX
0001355576
Smith Michael P
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
0
1
0
0
EVP, CFO, Treasurer & Sec.
Common Stock
2019-03-15
4
M
0
1563
0
A
1801
D
Common Stock
2019-03-15
4
F
0
541
51.88
D
1260
D
Restricted Stock Units
2019-03-15
4
M
0
1563
0
D
Common Stock
1563.0
4687
D
Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018.
Includes 238 shares purchased under the company's employee stock purchase plan which were not previously reported pursuant to the exemption under Rule 16b-3(c).
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units granted to the Reporting Person.
Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock.
Not applicable.
/s/ Thomas Doyle, Attorney-in-fact for Michael Smith
2019-03-19